These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 39373300

  • 61. Concordance of two polymerase chain reaction-based blood group genotyping platforms for patients with sickle cell disease.
    Sheppard CA, Bolen NL, Meny G, Kalvelage M, Ochoa-Garay G.
    Immunohematology; 2020 Dec; 36(4):123-128. PubMed ID: 33544616
    [Abstract] [Full Text] [Related]

  • 62. Frequency of Red Blood Cell Antigens According to Parent Ethnicity in Korea Using Molecular Typing.
    Shin KH, Lee HJ, Kim HH, Hong YJ, Park KU, Kim MJ, Kwon JR, Choi YS, Kim JN.
    Ann Lab Med; 2018 Nov; 38(6):599-603. PubMed ID: 30027705
    [Abstract] [Full Text] [Related]

  • 63. Optimal blood grouping and antibody screening for safe transfusion.
    Makarovska-Bojadzieva T, Blagoevska M, Kolevski P, Kostovska S.
    Prilozi; 2009 Jul; 30(1):119-28. PubMed ID: 19736535
    [Abstract] [Full Text] [Related]

  • 64. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R, Hendrickson JE.
    Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
    [Abstract] [Full Text] [Related]

  • 65. From the investigation of RHD-CE hybrid genes to the recognition of RHCE variants and RHD zygosity. Expanding the analysis by QMPSF in Brazilian donors and in patients with sickle cell disease.
    de Paula Vendrame TA, Arnoni CP, Latini FRM, Pereira Cortez AJ, Bénech C, Fichou Y, Castilho L.
    Blood Transfus; 2023 May; 21(3):202-208. PubMed ID: 35848626
    [Abstract] [Full Text] [Related]

  • 66. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Rankin A, Darbari D, Campbell A, Webb J, Mo YD, Jacquot C, Delaney M, Luban NLC, Nickel RS.
    Transfusion; 2021 Aug; 61(8):2255-2264. PubMed ID: 34002408
    [Abstract] [Full Text] [Related]

  • 67. Phenotype frequencies of Rh (C, c, E, e), M, Mia and Kidd blood group systems among ethnic Thai blood donors from the north-east of Thailand.
    Romphruk AV, Butryojantho C, Jirasakonpat B, Junta N, Srichai S, Puapairoj C, Simtong P.
    Int J Immunogenet; 2019 Jun; 46(3):160-165. PubMed ID: 30884143
    [Abstract] [Full Text] [Related]

  • 68. RHCE and Kell genotyping and alloimmunization profile in patients with sickle cell disease in the Federal District of Brazil.
    Leite LE, da Silva FG, Kashima S, Rodrigues ES, Haddad R.
    Hematol Transfus Cell Ther; 2024 Jun; 46(3):261-267. PubMed ID: 37344342
    [Abstract] [Full Text] [Related]

  • 69. RH genotype matching for transfusion support in sickle cell disease.
    Chou ST, Evans P, Vege S, Coleman SL, Friedman DF, Keller M, Westhoff CM.
    Blood; 2018 Sep 13; 132(11):1198-1207. PubMed ID: 30026182
    [Abstract] [Full Text] [Related]

  • 70. Prevalence of red blood cell alloantibodies in pregnant women with sickle cell disease in Bamako.
    Fomba M, Toure B, N'dour CT, Bagayoko A, Baby M.
    Transfus Med; 2024 Oct 13; 34(5):421-427. PubMed ID: 39104031
    [Abstract] [Full Text] [Related]

  • 71. Molecular blood group screening in Omani blood donors.
    Al-Riyami AZ, Al Hinai D, Al-Rawahi M, Al-Hosni S, Al-Zadjali S, Al-Marhoobi A, Al-Khabori M, Al-Riyami H, Denomme GA.
    Vox Sang; 2022 Mar 13; 117(3):424-430. PubMed ID: 34647328
    [Abstract] [Full Text] [Related]

  • 72. Benefits of blood group genotyping in multi-transfused patients from the south of Brazil.
    Guelsin GA, Sell AM, Castilho L, Masaki VL, Melo FC, Hashimoto MN, Higa TT, Hirle LS, Visentainer JE.
    J Clin Lab Anal; 2010 Mar 13; 24(5):311-6. PubMed ID: 20872565
    [Abstract] [Full Text] [Related]

  • 73. Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.
    Guelsin GA, Rodrigues C, Visentainer JE, De Melo Campos P, Traina F, Gilli SC, Saad ST, Castilho L.
    Blood Transfus; 2015 Jan 13; 13(1):53-8. PubMed ID: 24960644
    [Abstract] [Full Text] [Related]

  • 74. [Transfusion and alloimmunization in sickle cell anemia patients].
    Norol F, Nadjahi J, Bachir D, Desaint C, Guillou Bataille M, Beaujean F, Bierling P, Bonin P, Galacteros F, Duedari N.
    Transfus Clin Biol; 1994 Jan 13; 1(1):27-34. PubMed ID: 8186850
    [Abstract] [Full Text] [Related]

  • 75. Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program.
    Dinardo CL, Oliveira TGM, Kelly S, Ashley-Koch A, Telen M, Schmidt LC, Castilho S, Melo K, Dezan MR, Wheeler MM, Johnsen JM, Nickerson DA, Jain D, Custer B, Pereira AC, Sabino EC, NHLBI Recipient Epidemiology Donor Evaluation Study (REDS-III) International Component-Brazil, the Outcome Modifying Genes in SCD (OMG) study and the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program Sickle Cell Disease Working Group.
    Transfusion; 2021 Feb 13; 61(2):603-616. PubMed ID: 33231305
    [Abstract] [Full Text] [Related]

  • 76. Molecular genotyping of clinically important blood group antigens in patients with thalassaemia.
    Kulkarni S, Choudhary B, Gogri H, Patil S, Manglani M, Sharma R, Madkaikar M.
    Indian J Med Res; 2018 Dec 13; 148(6):713-720. PubMed ID: 30778005
    [Abstract] [Full Text] [Related]

  • 77. High frequency of partial DIIIa and DAR alleles found in sickle cell disease patients suggests increased risk of alloimmunization to RhD.
    Castilho L, Rios M, Rodrigues A, Pellegrino J, Saad ST, Costa FF.
    Transfus Med; 2005 Feb 13; 15(1):49-55. PubMed ID: 15713129
    [Abstract] [Full Text] [Related]

  • 78. Sickle cell disease patients in two London trusts: Genotyping including RH variants.
    Hui YMT, Gurung K, Layton DM, Ibidapo M, Grimsley S, Regan F.
    Transfus Med; 2022 Jun 13; 32(3):210-220. PubMed ID: 34850464
    [Abstract] [Full Text] [Related]

  • 79. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients.
    Dezan MR, Ribeiro IH, Oliveira VB, Vieira JB, Gomes FC, Franco LAM, Varuzza L, Ribeiro R, Chinoca KZ, Levi JE, Krieger JE, Pereira AC, Gualandro SFM, Rocha VG, Mendrone-Junior A, Sabino EC, Dinardo CL.
    Blood Cells Mol Dis; 2017 Jun 13; 65():8-15. PubMed ID: 28388467
    [Abstract] [Full Text] [Related]

  • 80. First investigation of RH gene polymorphism in patients with sickle cell disease and associated blood donors in Cameroon, Central Africa.
    Mbeti JMM, Bénech C, Sack FN, Wete E, Pangetha HN, Ateba SN, Tchatchueng J, Nloga AN, Fichou Y.
    Blood Transfus; 2024 Sep 13; 22(5):377-386. PubMed ID: 38315540
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.